IRIS Accounts Production v24.1.0.578 13862627 director 1.12.22 30.11.23 30.11.23 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh138626272022-11-30138626272023-11-30138626272022-12-012023-11-30138626272022-01-19138626272022-01-202022-11-30138626272022-11-3013862627ns15:EnglandWales2022-12-012023-11-3013862627ns14:PoundSterling2022-12-012023-11-3013862627ns10:Director12022-12-012023-11-3013862627ns10:PrivateLimitedCompanyLtd2022-12-012023-11-3013862627ns10:SmallEntities2022-12-012023-11-3013862627ns10:AuditExempt-NoAccountantsReport2022-12-012023-11-3013862627ns10:SmallCompaniesRegimeForDirectorsReport2022-12-012023-11-3013862627ns10:SmallCompaniesRegimeForAccounts2022-12-012023-11-3013862627ns10:FullAccounts2022-12-012023-11-3013862627ns10:RegisteredOffice2022-12-012023-11-3013862627ns5:CurrentFinancialInstruments2023-11-3013862627ns5:CurrentFinancialInstruments2022-11-3013862627ns5:Non-currentFinancialInstruments2023-11-3013862627ns5:Non-currentFinancialInstruments2022-11-3013862627ns5:ShareCapital2023-11-3013862627ns5:ShareCapital2022-11-3013862627ns5:RetainedEarningsAccumulatedLosses2023-11-3013862627ns5:RetainedEarningsAccumulatedLosses2022-11-3013862627ns5:CostValuation2022-11-3013862627ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-11-3013862627ns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-11-30
REGISTERED NUMBER: 13862627 (England and Wales)















Unaudited Financial Statements for the Year Ended 30 November 2023

for

Cavendish Laboratories Holdings Limited

Cavendish Laboratories Holdings Limited (Registered number: 13862627)






Contents of the Financial Statements
for the Year Ended 30 November 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


Cavendish Laboratories Holdings Limited

Company Information
for the Year Ended 30 November 2023







DIRECTOR: Mrs R T Knight





REGISTERED OFFICE: The Old Grange
Warren Estate
Lordship Road
Writtle
Essex
CM1 3WT





REGISTERED NUMBER: 13862627 (England and Wales)





ACCOUNTANTS: Fisher Michael
The Old Grange
Warren Estate
Lordship Road
Writtle
Essex
CM1 3WT

Cavendish Laboratories Holdings Limited (Registered number: 13862627)

Balance Sheet
30 November 2023

2023 2022
Notes £    £    £    £   
FIXED ASSETS
Investments 4 400,000 400,000

CURRENT ASSETS
Debtors 5 500 500

CREDITORS
Amounts falling due within one year 6 1,440 780
NET CURRENT LIABILITIES (940 ) (280 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

399,060

399,720

CREDITORS
Amounts falling due after more than one
year

7

150,000

400,000
NET ASSETS/(LIABILITIES) 249,060 (280 )

CAPITAL AND RESERVES
Called up share capital 500 500
Retained earnings 248,560 (780 )
249,060 (280 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 November 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 November 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 8 April 2024 and were signed by:




Mrs R T Knight - Director


Cavendish Laboratories Holdings Limited (Registered number: 13862627)

Notes to the Financial Statements
for the Year Ended 30 November 2023

1. STATUTORY INFORMATION

Cavendish Laboratories Holdings Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The company is part of a group.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Significant judgements and estimates
No significant judgements or estimates have been applied in the preparation of the financial statements.

Financial instruments
The company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like debtors and creditors, loans from third parties, loans to related parties and investments in ordinary shares.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Debtors
Short term debtors are measured at the transaction price, less any impairment.

Creditors
Short term creditors are measured at the transaction price.

Other financial liabilities, including loans are also measured at transaction price since the difference between this basis and the amortised cost basis is not material.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2022 - 1 ) .

Cavendish Laboratories Holdings Limited (Registered number: 13862627)

Notes to the Financial Statements - continued
for the Year Ended 30 November 2023

4. FIXED ASSET INVESTMENTS
Other
investments
£   
COST
At 1 December 2022
and 30 November 2023 400,000
NET BOOK VALUE
At 30 November 2023 400,000
At 30 November 2022 400,000

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Other debtors 500 500

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Other creditors 1,440 780

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2023 2022
£    £   
Bank loans 150,000 400,000